Significant Spike in Vaccine Stocks Covid-19 vaccine manufacturers experienced sharp increases in stock prices following reports of a new coronavirus study conducted in China. The report indicated a new bat coronavirus was identified with potential risks for animal-to-human transmission. Major Players in the Market Moderna saw its stock rise by 6.4%, BioNTech's American Depositary Receipts (ADRs) increased by 5.1%, while Pfizer and Novavax saw gains of 1.7% and 7.3%, respectively. Research Findings and Implications A recent report highlighted that the new virus shares a similar human receptor with the virus that causes Covid-19, which could have significant implications for public health and the biotechnology industry.